DUBLIN & MUNICH--(BUSINESS WIRE)--LUMA Vision, developer of a novel four-dimensional (4D) cardiac imaging and navigation platform, today announced a total of $22 million in new financing for the ...
LUMA Vision, maker of a 4D cardiac imaging and navigation platform that uses machine learning, announced it secured $22 million in Series A3 financing. The round was led by existing investors ABV Uni ...
DUBLIN, Feb. 2, 2026 /PRNewswire/ -- LUMA Vision Ltd., a leader in next-generation cardiac 4D navigation and imaging, today announced that its proprietary VERAFEYE™ System will be showcased in a ...
DUBLIN, March 19, 2026 /PRNewswire/ -- LUMA Vision, a leader in cardiac 4D imaging and navigation, today announces the expansion of its clinical program with the first patient enrolments in two ...
DUBLIN, Jan. 14, 2025 /PRNewswire/ -- LUMA Vision Ltd., an innovative leader in Cardiac Navigation and Visualization technology, proudly announces the successful first-in-human use and enrollment in ...
Luma Vision Ltd. raised $22 million in financing that will allow the company to secure U.S. FDA approval and prepare for commercialization of its 4D cardiac imaging technology platform, Verafeye. The ...
DUBLIN, April 21, 2026 /PRNewswire/ -- LUMA Vision, a leader in real-time 4D cardiac imaging and navigation, today announced its participation in the Heart Rhythm Society Annual Meeting (HRS 2026) in ...
DUBLIN, Jan. 7, 2026 /PRNewswire/ -- LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYE™-guided persistent atrial fibrillation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results